|
CCDC21 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.057200E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.41399999999503E-05 |
| Normal-vs-Stage2 |
1.692230E-01 |
| Normal-vs-Stage3 |
1.166430E-01 |
| Normal-vs-Stage4 |
7.250400E-01 |
| Stage1-vs-Stage2 |
2.227800E-01 |
| Stage1-vs-Stage3 |
1.522850E-01 |
| Stage1-vs-Stage4 |
1.436020E-01 |
| Stage2-vs-Stage3 |
9.675800E-01 |
| Stage2-vs-Stage4 |
5.399800E-01 |
| Stage3-vs-Stage4 |
4.805000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.482200E-03 |
| Normal-vs-AfricanAmerican |
1.364510E-03 |
| Normal-vs-Asian |
7.816400E-01 |
| Caucasian-vs-AfricanAmerican |
7.346000E-01 |
| Caucasian-vs-Asian |
8.028400E-02 |
| AfricanAmerican-vs-Asian |
5.027700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.240190E-04 |
| Normal-vs-Female |
1.948030E-01 |
| Male-vs-Female |
1.512490E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.340600E-03 |
| Normal-vs-Extreme_Weight |
3.8259000000318E-06 |
| Normal-vs-Obese |
1.483650E-03 |
| Normal-vs-Extreme_Obese |
1.245970E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.989800E-01 |
| Normal_Weight-vs-Obese |
7.840800E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.964200E-01 |
| Extreme_Weight-vs-Obese |
2.596400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.805000E-01 |
| Obese-vs-Extreme_Obese |
6.715000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.162800E-01 |
| Normal-vs-Age(41-60Yrs) |
3.390500E-04 |
| Normal-vs-Age(61-80Yrs) |
5.940100E-03 |
| Normal-vs-Age(81-100Yrs) |
1.590280E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.796000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.156610E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.120770E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.865800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.269700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.055200E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.25049999974725E-07 |
| Normal-VS-Type2 PRCC |
1.999780E-02 |
| Normal-VS-KIRP CIMP |
4.330200E-01 |
| Normal-VS-Unclassified PRCC |
8.059600E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.226610E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.2254999999991E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
1.044050E-02 |
| Type2 PRCC-VS-KIRP CIMP |
3.429800E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
5.054000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.781800E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.875610E-02 |
| Normal-vs-N1 |
4.451400E-01 |
| Normal-vs-N2 |
5.107600E-01 |
| N0-vs-N1 |
2.126000E-01 |
| N0-vs-N2 |
6.927800E-01 |
| N1-vs-N2 |
8.504600E-01 |
|
|
